Overview
Amy Curran is a Hematologist in Phoenixville, Pennsylvania. Dr. Curran is highly rated in 16 conditions, according to our data. Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, Pleuropulmonary Blastoma, and Lung Cancer.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
824 Main St Ste 101, Phoenixville, PA 19460
Abramson Cancer Center Perelman 4th Floor West
Stephen Schuster is a Hematologist in Philadelphia, Pennsylvania. Dr. Schuster is highly rated in 27 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.
University Of Penn-Medical Group
Adam Cuker is a Hematologist in Philadelphia, Pennsylvania. Dr. Cuker is highly rated in 26 conditions, according to our data. His top areas of expertise are Thrombocytopenia, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Splenectomy, and Knee Replacement.
Abramson Cancer Center Perelman 4th Floor West
Stefan Barta is a Hematologist in Philadelphia, Pennsylvania. Dr. Barta is highly rated in 37 conditions, according to our data. His top areas of expertise are Non-Hodgkin Lymphoma, T-Cell Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Barta is currently accepting new patients.
Frequently Asked Questions about Dr. Amy Curran
How do I make an appointment with Dr. Amy Curran?
You can book an appointment with Dr. Amy Curran by calling their office at 610-983-1800. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Amy Curran a top-rated expert for Chronic Lymphocytic Leukemia (CLL)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amy Curran is classified as an Distinguished expert for Chronic Lymphocytic Leukemia (CLL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Amy Curran specialize in?
While Dr. Amy Curran is a Hematology, they have specific expertise in Chronic Lymphocytic Leukemia (CLL), Paget Disease of the Breast, and Pleuropulmonary Blastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chronic Lymphocytic Leukemia (CLL)Dr. Curran isDistinguished. Learn about Chronic Lymphocytic Leukemia (CLL).
- Advanced
- AngiosarcomaDr. Curran isAdvanced. Learn about Angiosarcoma.
- Breast CancerDr. Curran isAdvanced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Dr. Curran isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Deep Vein ThrombosisDr. Curran isAdvanced. Learn about Deep Vein Thrombosis.
- End-Stage Renal Disease (ESRD)Dr. Curran isAdvanced. Learn about End-Stage Renal Disease (ESRD).
- Familial Prostate CancerDr. Curran isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- Activated PI3K Delta Syndrome (APDS)Dr. Curran isExperienced. Learn about Activated PI3K Delta Syndrome (APDS).
- Acute Hepatic Porphyria (AHP)Dr. Curran isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Mountain SicknessDr. Curran isExperienced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Curran isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Curran isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Curran isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.